RB1 and neoplasm: Figure 6b revealed significant increases in tumor accumulation of PL-RB compared with rituximab (**p = 0.005) and 11B8 (**p = 0.004). Additionally, the frozen sections of the tumor tissues were prepared for IF staining and observed by CLSM (Fig. 6c).